Announcement PDF ASX: CCO Quarterly Results Presentation Q2 2026 30 January 2026 STRATEGIC PILLARS Regional Sourcing & Innovation THE WORLD’S LEADING NATURAL RELAXATION COMPANY - PACIFIC ISLAND REGIONAL SOURCING - FIJI EXCELLENCE IN QA & SERVICE - CO2 EXTRACTION - BLOCKCHAIN TRACEABILITY Direct to Consumer Inc. Amazon Profitable & Scalable Retail Wholesale (Bulk) Ingredients - AMAZON USA & AU - SALESFORCE WEBSITES (FK, TM and DN) - HIGH-MARGIN, HIGH- AWARENESS DTC FOCUS - MA JOR RETAIL - SUPPORTING PHARMACY & NUTRITION - HIGH-EXPOSURE, TRIAL & RESALE TO MAINSTREAM - AU & GLOBAL - BEVERAGE & KAVA SNACK BRANDS - COMPLEMENTARY MEDICINES - CO-MANUFACTURE & FLAVOUR HOUSES - KAVA HOSPITALITY Vs Q4,25 33% Calmer Co Sets Sales Record in December - $910k USA Finds Sales Traction Up 9% New Sales Record in December United States sales reached $1.01 million, representing a 9% quarter-on-quarter increase, with the U.S. now contributing 51% of total group revenue. Growth was driven by continued momentum on Amazon alongside expansion of the wholesale channel December 2025 delivered record monthly of revenue of $910k the strongest result in the history of The Calmer Co. The wholesale channel recorded its strongest monthly revenue of $340k, with YTD wholesale revenues already exceeding total FY25 annual sales in the first half of FY26. $926k Australian Sales $1.01m USA Sales Vs Q4,25 9% Vs Q1FY26 USA Finds Sales Traction $2.01m Q2 FY26 Total Global Sales Vs Q1FY 26 USA SALES PASS $1m AND 51% OF REVENUE US sales increased 9% to $1.01m for the quarter, driven primarily by strong performance on Amazon Marketplace. The U.S. now accounts for 51% of group revenue and continues to grow, with broad consumer adoption across both e-commerce and wholesale channels underpinning our U.S. growth trajectory USA sales growth driven by expanding Amazon product range including tinctures, capsules and flavoured kava shots with the total wholesale channel increasing 15% QoQ to $362,000 (Q1 FY26: $314,000). Approximately 94% of wholesale revenue was generated in the United States, reflecting the Company’s strategic focus and execution in the world’s largest kava market . $387,000 $305,000 $775,000 $935,000 $1,010,000 $100,000 $200,000 $300,000 $400,000 $500,000 $600,000 $700,000 $800,000 $900,000 $1,000,000 $1,100,000 Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 Q2FY26 USA Sales Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26 Q2FY26 RETAIL SALES UP 42% ON PCP $525,000 $648,000 $684,000 $1,150,000 $743,000 $0 $200,000 $400,000 $600,000 $800,000 $1,000,000 $1,200,000 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Retail Sales by Quarter Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Woolworths Pipeline Fill Q1FY26 Total retail sales were up 42% to $743k on prior corresponding period (PCP). Coles Synergy Data confirmed Fiji Kava® as a major contributor to category growth, accounting for +33% of the stress sub-category, with: #1 ranked product: 150g Instant Kava #3 ranked product: 50g Instant Kava These results highlight strong brand leadership and growing consumer acceptance within mainstream retail. E-COMMERCE CONTINUES TO LEAD GROWTH E-commerce remained the Group’s largest channel, generating $905,000 in revenue and representing 45% of total Group sales, reinforcing its role as the Company’s primary growth engine. Quarter-on-quarter performance reflected normalisation following Q1 promotional activity, with underlying demand remaining strong and channel economics intact. Amazon USA continued to demonstrate resilience and scale, delivering $652,000 in revenue, up 2% QoQ, and maintaining its position as the Company’s single largest marketplace. Premium brand mix strengthened materially, with Taki Mai® now accounting for up to 43% of Amazon revenue, compared to 7% in January 2025, highlighting successful execution of the Company’s Pacific-sourced, provenance-led brand strategy. Direct-to-Consumer (DTC) revenue totalled $252,000, supported by ongoing investment in advertising creative, content optimisation and conversion rate improvements. E-commerce positioned for renewed growth in Q3 FY26, underpinned by enhanced creative performance, planned product range expansion across powdered formats, and upcoming TGA-submitted product launches. WHOLESALE STRONG GROWTH, UP 15%. Wholesale revenue increased 15% quarter-on-quarter to $362,000, representing 18% of total Group revenue. Growth was driven by repeat orders from existing water-extract customers, including IMCD, and multiple U.S. resellers. The quarter also included repeat commercial sale of The Calmer Co.’s CO₂ extract to a U.S. beverage partner, marking continued progress in the Company’s higher-value B2B strategy and reinforcing confidence in wholesale demand as production formats scale. $362k Wholesale Revenue 15% Vs Q1,26 0 50000 100000 150000 200000 250000 300000 350000 400000 Q3 FY25 Q4FY25 Q1FY26 Q2FY26 Wholesale Revenue Q3 FY25 Q4FY25 Q1FY26 Q2FY26 CASH, INVENTORY & SUBSCRIPTIONS The Company remains focused on disciplined working capital management as it scales, closing the quarter with cash on hand of $1.03 million and additional financing capacity in place to support continued growth initiatives. $700k secured under Tranche Two of the convertible note facility subsequent to quarter end, strengthening liquidity and supporting wholesale inventory build and growth initiatives. Cash on Hand The business has $1.03m at bank with cash receipts rising. Inventory Stable Inventory levels are strong and new product formats are in our USA warehouse. Subscriptions Rising Monthly subscriptions continue to rise. $280k of inventory is presold in subscriptions RTD Format to Grow RTD beverages represent only 4-5% of our revenue mix. RTDs are a key component of our growth plan. Growth Funding in Place RECORD PERFORMANCE AND ACCELERATING U.S MOMENTUM “December was a standout month for The Calmer Co., with record monthly revenue of $910,767 and our wholesale channel delivering its strongest performance to date, generating $340,131 in sales. Year-to- date revenue has already surpassed our FY25 full-year results, highlighting the accelerating global demand for premium, fully traceable kava ingredients. We are particularly encouraged by the momentum in the United States, a consumer market significantly larger than Australia. U.S. sales now represent more than 50% of our total global revenue and continue to accelerate. During the quarter, U.S.-based sales increased by 9%, while the wholesale division grew by 15%. We see substantial upside in the U.S. market.” Zane Yoshida Founder & CEO The Calmer CoCo Investor Hub To find this full report and other ASX releases please go to our Investor Centre. Join the Conversation on Investor Hub Q2 FY26 Results Webinar Join CEO Zane Yoshida, at The Calmer Co (ASX: CCO) investor webinar to discuss the Q2 FY26 performance, activities and focus. Date: Friday February 6th, 2026 Time: 9am (AEST) Register here for Quarterly Investor Webinar http://thecalmerco.com